Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiedu Qingfei Dripping Pills (解毒清肺滴丸) is a Traditional Chinese Medicine (TCM) candidate developed by Shaanxi Kanghui Pharmaceutical. It is formulated as dripping pills for oral administration, specifically targeting lung and respiratory conditions. The development of this drug has been recognized and supported by the Chinese National Ministry of Science and Technology and the Ministry of Health as part of the "Major New Drug Creation" special project. The formulation is designed to provide "detoxification and lung-clearing" (解毒清肺) therapeutic effects, which is a traditional approach to treating inflammatory or infectious respiratory ailments. As a TCM product, its pharmacological profile is based on the synergistic effects of multiple herbal components rather than a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiedu Qingfei Dripping Pills.